Top Markets
#1 Tensor Tensor +38.76%
#2 Dymension Dymension +20.19%
#3 Ontology Gas Ontology Gas +19.99%
#4 Blur Blur +19.25%
#5 XPIN Network XPIN Network +12.27%
#6 Naoris Protocol Naoris Protocol +12.17%
#7 Corn Corn +10.72%
#8 Irys Irys +10.19%
#9 Magma Finance Magma Finance +9.13%
#10 Enjin Coin Enjin Coin +8.97%
Coin of the day
Tensor Tensor
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Clinical Laserthermia Systems AB (publ) Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B
Kedudukan dalam Saham #16822
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased... Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Harga Saham
$0.51099792
Modal Pasaran
$13.22M
Perubahan (1 hari)
-0.54%
Perubahan (1 tahun)
99.27%
Negara
SE
Perdagangan Clinical Laserthermia Systems AB (publ) (CLS-B)

Kategori

Healthcare
Nisbah P/E bagi Clinical Laserthermia Systems AB (publ) (CLS-B)
Nisbah P/E pada April 2026 TTM: -3.33
Menurut laporan kewangan dan harga saham terkini Clinical Laserthermia Systems AB (publ), nisbah P/E semasa (TTM) ialah -3.33. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak -1.16.
Sejarah nisbah P/E bagi Clinical Laserthermia Systems AB (publ) dari 2008 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -3.33 292.28%
2024 -0.85 -27.17%
2023 -1.16 15.77%
2022 -1.00 -72.89%
2021 -3.70 5.14%
2020 -3.52 -26.19%
2019 -4.77 -26.87%
2018 -6.52 -67.78%
2017 -20.25 141.77%
2016 -8.38 -21.66%
2015 -10.69 42.64%
2014 -7.50 -49.75%
2013 -14.92 -99.55%
2012 -3.35K -61.32%
2011 -8.65K -28.04%
2010 -12.02K -14.03%
2009 -13.98K 5,171.83%
2008 -265.26 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 27.47 -923.88%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 38.72 -1,261.23%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 24.08 -822.10%
IE
Medtronic Medtronic
Medtronic
MDT.US
 24.08 -822.10%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 32.19 -1,065.50%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.